Dr. Chima Nwaukwa, M.D.
What this data tells you about Dr. Nwaukwa
Dr. Chima Nwaukwa is a cardiovascular disease in Beaumont, TX, with 19 years in practice. Based on federal Medicare data, Dr. Nwaukwa performed 1,839 Medicare services across 1,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nwaukwa received a total of $34,740 from 31 pharmaceutical and/or device companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nwaukwa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 561 | $86 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 180 | $41 | $150 |
| Echocardiogram, transthoracic | 155 | $134 | $1,000 |
| Hospital follow-up visit, moderate complexity | 147 | $61 | $250 |
| Electrocardiogram (EKG), 12-lead | 142 | $10 | $100 |
| Initial hospital admission, moderate complexity | 82 | $101 | $450 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $47 | $500 |
| Ultrasound scan of abdominal aorta | 55 | $102 | $750 |
| Office visit, established patient, complex (40-54 min) | 55 | $126 | $400 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $315 | $1,400 |
| Ultrasound of both sides of head and neck blood flow | 49 | $138 | $1,000 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 47 | $81 | $119 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $10 | $100 |
| New patient office visit (45-59 min) | 38 | $111 | $500 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 26 | $622 | $2,000 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $20 | $500 |
| Programming of dual lead pacemaker system | 24 | $58 | $200 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $139 | $1,000 |
| Cardiac catheterization | 19 | $204 | $1,100 |
| Ultrasound study of arm and leg arteries | 17 | $49 | $500 |
| Office visit, established patient (20-29 min) | 17 | $62 | $200 |
| Ultrasound of leg arteries or artery grafts | 15 | $176 | $1,200 |
| Hospital follow-up visit, low complexity | 12 | $39 | $200 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nwaukwa is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nwaukwa experienced with office visit, established patient (30-39 min)?
Does Dr. Nwaukwa receive payments from pharmaceutical companies?
How do Dr. Nwaukwa's costs compare to other cardiovascular diseases in Beaumont?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology